Immutep Limited

The momentum for this stock is not very good. Immutep Limited is not a good value stock. Immutep Limited is not a good growth stock. Immutep Limited is not very popular among insiders. Immutep Limited is a mediocre stock to choose.
Log in to see more information.
Immutep Ltd. is a biotechnology company, which engages in the research and development of immunother...

News

JPMorgan Acquires Substantial Stake in Immutep Ltd
JPMorgan Acquires Substantial Stake in Immutep Ltd

TipRanks Financial Blog Immutep Ltd (AU:IMM) has released an update. JPMorgan Chase & Co. has emerged as a substantial holder in Immutep Ltd, securing a 5.10% voting power through 74,142,6...\n more…

Immutep Ltd (PRRUF) Receives a Buy from Wilsons
Immutep Ltd (PRRUF) Receives a Buy from Wilsons

TipRanks Financial Blog In a report released on September 9, Melissa Benson from Wilsons maintained a Buy rating on Immutep Ltd (PRRUF - Research Report), with a price tar...\n more…

Immutep's Innovative LAG-3 Focused Therapies Poised to Transform Advanced Cancer Treatments: A Buy Rating Overview
Immutep's Innovative LAG-3 Focused Therapies Poised to Transform Advanced Cancer Treatments: A Buy Rating Overview

TipRanks Financial Blog Immutep (IMMP - Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Naureen Quibria from Capital...\n more…

FY2025 Earnings Forecast for Immutep Limited Issued By Capital One Financial (NASDAQ:IMMP)
FY2025 Earnings Forecast for Immutep Limited Issued By Capital One Financial (NASDAQ:IMMP)

Zolmax Immutep Limited (NASDAQ:IMMP - Free Report) - Investment analysts at Capital One Financial increased their FY2025 EPS estimates for shares of Immutep in a report issued on Tuesday, September 3rd...\n more…

FY2025 Earnings Forecast for Immutep Limited Issued By Capital One Financial (NASDAQ:IMMP)
FY2025 Earnings Forecast for Immutep Limited Issued By Capital One Financial (NASDAQ:IMMP)

Ticker Report Immutep Limited (NASDAQ:IMMP - Free Report) - Investment analysts at Capital One Financial increased their FY2025 EPS estimates for shares of Immutep in a report issued on Tuesday, September 3rd...\n more…

Capital One Financial Comments on Immutep Limited's FY2029 Earnings (NASDAQ:IMMP)
Capital One Financial Comments on Immutep Limited's FY2029 Earnings (NASDAQ:IMMP)

Zolmax Immutep Limited (NASDAQ:IMMP - Free Report) - Equities researchers at Capital One Financial lifted their FY2029 earnings per share estimates for shares of Immutep in a research note issued to...\n more…